Clinical Trial Update: Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating ursodeoxycholic acid with low-dose glucocorticoid for primary biliary cholangitis with autoimmune features.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis
• Biliary Cholangitis

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: West China Hospital | Conditions: Hepatitis, Autoimmune, Primary Biliary Cholangitis | Phase 4 | Status: UNKNOWN